Taken together, TFCP2-rearranged sarcoma likely represents a separate entity characterized by distinct transcriptional and DNA methylation profiles, an unusual degree of genomic instability, truncated ALK variants, ALK and TERT overexpression, and recurrent CDKN2A/MTAP co-deletions. The gene discussed is CDKN2A; the disease is sarcoma.